Lara Longpre - 10 Nov 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Development Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2021
Net transactions value
+$10,177
Form type
4
Filing time
15 Nov 2021, 15:19:29 UTC
Previous filing
01 Oct 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $10,177 +753 +0.89% $13.52 84,998 10 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 753 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.